These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 34248945)

  • 1. Monocyte and Macrophage miRNA: Potent Biomarker and Target for Host-Directed Therapy for Tuberculosis.
    Sampath P; Periyasamy KM; Ranganathan UD; Bethunaickan R
    Front Immunol; 2021; 12():667206. PubMed ID: 34248945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs in immune responses to Mycobacterium tuberculosis infection.
    Yang T; Ge B
    Cancer Lett; 2018 Sep; 431():22-30. PubMed ID: 29803788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to
    Kundu M; Basu J
    Front Immunol; 2021; 12():687962. PubMed ID: 34248974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA in innate immunity and autophagy during mycobacterial infection.
    Kim JK; Kim TS; Basu J; Jo EK
    Cell Microbiol; 2017 Jan; 19(1):. PubMed ID: 27794209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers.
    Sinigaglia A; Peta E; Riccetti S; Venkateswaran S; Manganelli R; Barzon L
    Cells; 2020 Sep; 9(10):. PubMed ID: 32987746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.
    Sabir N; Hussain T; Shah SZA; Peramo A; Zhao D; Zhou X
    Front Microbiol; 2018; 9():602. PubMed ID: 29651283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK.
    Chen DY; Chen YM; Lin CF; Lo CM; Liu HJ; Liao TL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis.
    Sampath P; Moorthy M; Menon A; Madhav L; Janaki A; Dhanapal M; Natarajan AP; Hissar S; Ranganathan UD; Ramaswamy G; Bethunaickan R
    Front Immunol; 2023; 14():1197805. PubMed ID: 37457712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-23a-5p modulates mycobacterial survival and autophagy during mycobacterium tuberculosis infection through TLR2/MyD88/NF-κB pathway by targeting TLR2.
    Gu X; Gao Y; Mu DG; Fu EQ
    Exp Cell Res; 2017 May; 354(2):71-77. PubMed ID: 28327409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as immune regulators and biomarkers in tuberculosis.
    Wang L; Xiong Y; Fu B; Guo D; Zaky MY; Lin X; Wu H
    Front Immunol; 2022; 13():1027472. PubMed ID: 36389769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
    Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
    Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
    Mohareer K; Asalla S; Banerjee S
    Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of miRNAs by macrophages infected with virulent and avirulent Mycobacterium tuberculosis.
    Das K; Saikolappan S; Dhandayuthapani S
    Tuberculosis (Edinb); 2013 Dec; 93 Suppl():S47-50. PubMed ID: 24388649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNAs in tuberculosis: Their decisive role in the fate of TB.
    Alipoor SD; Adcock IM; Tabarsi P; Folkerts G; Mortaz E
    Eur J Pharmacol; 2020 Nov; 886():173529. PubMed ID: 32919937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155-regulated molecular network orchestrates cell fate in the innate and adaptive immune response to Mycobacterium tuberculosis.
    Rothchild AC; Sissons JR; Shafiani S; Plaisier C; Min D; Mai D; Gilchrist M; Peschon J; Larson RP; Bergthaler A; Baliga NS; Urdahl KB; Aderem A
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6172-E6181. PubMed ID: 27681624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA research: The new dawn of Tuberculosis.
    Mehta P
    Indian J Tuberc; 2021 Jul; 68(3):321-329. PubMed ID: 34099196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF Dependent Differential Control of
    Mishra A; Singh VK; Actor JK; Hunter RL; Jagannath C; Subbian S; Khan A
    Front Immunol; 2020; 11():1599. PubMed ID: 32793233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.